MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0025639
Satyadivis Pharmaceuticals Private Limited - pharma in Jinnaram, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹67.35 Cr
▲ 2% YoY
Net profit · FY 2024
₹16.57 Cr
Net margin 24.6%
EBITDA · FY 2024
₹25.66 Cr
EBITDA margin 38.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹76.55 Lakh
Issued & subscribed
Satisfied charges
₹18.55 Cr
No open charges
Company age
34 yrs
Est. 1992
Employees · EPFO
64
Provident fund records
About Satyadivis Pharmaceuticals Private Limited
Data last updated:
Satyadivis Pharmaceuticals Private Limited is a private limited company based in Jinnaram, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 October 1992 and has been in existence for over 34 years.
Its director Ramesh Babu Potluri and family are #1,090 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1992PTC014939. Its GSTIN is 36AAACD9889P1ZM (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹76.55 Lakh. It was formerly known as Divis Pharmaceuticals Pvt.Ltd and Divis Pharmaceuticals Pvt.Ltd. It is led by directors including Divi Satya Mohan (Managing Director) and Suryanarayana Simhadri.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No.10 Gaddapotaram (V) Khazipally I.D.A, Jinnaram, Telangana, India – 502319.
As per the financials filed for FY 2024, the company reported a revenue of ₹67.35 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹16.57 Cr (net margin 24.6%) and EBITDA of ₹25.66 Cr (EBITDA margin 38.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 20% over five years.
The company has about 64 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Divis Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹18.55 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
Satyadivis Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0025639). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website divispharma.com.
Company details
CIN U24239TG1992PTC014939
Registration Number 014939
Incorporation Date 27 October 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-09-0025639
Name history
Satyadivis Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Divis Pharmaceuticals Pvt.Ltd, and Divis Pharmaceuticals Pvt.Ltd.. The current legal name is Satyadivis Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Satyadivis Pharmaceuticals Private Limited | Current |
| Divis Pharmaceuticals Pvt.Ltd | Previous |
| Divis Pharmaceuticals Pvt.Ltd. | Previous |
CIN history
Satyadivis Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP1992PTC014939. The current CIN is U24239TG1992PTC014939, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1992PTC014939 | Current |
| U24239AP1992PTC014939 | Previous |
Key People
Divi Satya Mohan Managing Director Suryanarayana Simhadri Additional Director Ramesh Babu Potluri Additional Director Recognitions & Rankings of Satyadivis Pharmaceuticals
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,090 Ramesh Babu Potluri & family ₹2,400 Cr
Contact details
Satyadivis Pharmaceuticals Private Limited's registered office is in Jinnaram, Telangana. Its website is divispharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressSurvey No.10 Gaddapotaram (V) Khazipally I.D.A, Jinnaram, Telangana, India – 502319
- IndustryPharma, API Manufacturers
To see the full contact details of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Satyadivis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Satyadivis Pharmaceuticals operates one associated brand: Divis Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality active pharmaceutical ingredients and intermediates. | divispharma.com |
Business activity
The main business activity of Satyadivis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Financials of Satyadivis Pharmaceuticals Private Limited
FY 2025 filings availableSatyadivis Pharmaceuticals Private Limited reported revenue of ₹67.35 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹67.35 Cr ▲ 2%
Net profit · FY 2024
₹16.57 Cr margin 24.6%
EBITDA · FY 2024
₹25.66 Cr margin 38.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 6%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 2%
5 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 2% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 38.1% | ||||
| Net Profit Margin | 24.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Satyadivis Pharmaceuticals Private Limited
Satyadivis Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divi Satya Mohan | Managing Director | 27 Oct 1992 | 34 Years 0 Months | Current |
| Suryanarayana Simhadri Also directs: Tierra Agrotech Limited, Lakshmi Finance and Industrial Corporation Ltd, Sspdl Limited and 2 more | Additional Director | 30 Aug 2025 | 1 Years 2 Months | Current |
| Ramesh Babu Potluri Also directs: Potluri Agri Farms LLP, SMS Pharmaceuticals Limited, SMS Peptides Private Limited and 1 more | Additional Director | 19 Dec 2025 | 0 Years 10 Months | Current |
Peer comparison
Satyadivis Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanmar Speciality Chemicals Limited | ₹68.48 Cr (FY 2018) | 11.0% | Chennai, Tamil Nadu, India | |||
| Lohitha Life Sciences Private Limited | ₹67.8 Cr (FY 2024) | 7.0% | Hyderabad, Telangana, India | |||
| Beloorbayir Biotech Limited | ₹67.42 Cr (FY 2021) | -4.0% | Bangalore, Karnataka, India | |||
| Sandu Pharmaceuticals Limited | ₹67.36 Cr (FY 2025) | -1.0% | Goa, India | |||
| Satyadivis Pharmaceuticals Private Limitedthis company | ₹67.35 Cr (FY 2024) | ₹16.57 Cr | 24.6% | 2.0% | Jinnaram, Telangana, India | |
| Nakoda Chemicals Ltd | ₹67.34 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| La Chandra Pharmalab Private Limited | ₹67.31 Cr (FY 2025) | 40.0% | Ahmedabad, Gujarat, India | |||
| Pride Drugs and Pharma Private Limited | ₹66.89 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Seutic Pharma Private Limited | ₹66.83 Cr (FY 2025) | -24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Auditor
Satyadivis Pharmaceuticals Private Limited is audited by P. V. R. K. NAGESWARA RAO & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. V. R. K. NAGESWARA RAO & CO | FY 2023 | 002283S |
Shareholding
The shareholding of Satyadivis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹18.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 1998 | 90134135 | State Bank of India | ₹18 Cr | Satisfied | |
| 08 Feb 1994 | 90131938 | Andhra Pradesh State Financial Corporation | ₹55.3 Lakh | Satisfied |
To see the full charge records of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Satyadivis Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Satyadivis Pharmaceuticals, 2 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| District courts | 1 | 0 | 1 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against individuals | Pending |
| High Court for State of Telangana | Writ petition | Filed against the company | Disposed |
To see the full case history of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Satyadivis Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 41 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sr Prefabs Modular Cleanroom Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| G P C Flow Instruments Private Limited | |||
| United Farmtech Private Limited |
To see the full MSME payment records of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Satyadivis Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACD9889P1ZM | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Satyadivis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Satyadivis Pharmaceuticals Private Limited has 6 board changes on record since 1992: 4 appointments and 2 cessations. The latest: Ramesh Babu Potluri was appointed as Additional Director on 19 Dec 2025.
Appointed
Ramesh Babu Potluri was appointed as Additional Director.
AGM
Satyadivis Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Appointed
Suryanarayana Simhadri was appointed as Additional Director.
Filing
Satyadivis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 23 Jun 1998 via Charge ID 90134135 with State Bank Of India was fully satisfied on 21 Dec 2023.
Ceased
Murali Krishna Prasad Divi ceased to be Director.
Ceased
Nimmagadda Venkata Ramana ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 18.00 Cr registered on 23 Jun 1998 with Charge ID 90134135 was modified on 18 Mar 2011.
Charges
A charge registered on 08 Feb 1994 via Charge ID 90131938 with Andhra Pradesh State Financial Corporation was fully satisfied on 16 Mar 2000.
Charges
A charge with State Bank Of India amounted to Rs. 18.00 Cr with Charge ID 90134135 was registered on 23 Jun 1998.
Charges
A charge with Andhra Pradesh State Financial Corporation amounted to Rs. 0.55 Cr with Charge ID 90131938 was registered on 08 Feb 1994.
Appointed
Divi Radhakrishna Rao was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Satyadivis Pharmaceuticals is an active private limited company based in Jinnaram, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 October 1992 (34+ years old) and is registered under CIN U24239TG1992PTC014939.
Satyadivis Pharmaceuticals has 3 current directors:
- Divi Satya Mohan - Managing Director
- Suryanarayana Simhadri - Additional Director
- Ramesh Babu Potluri - Additional Director
The latest financial statements of Satyadivis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Satyadivis Pharmaceuticals is 36AAACD9889P1ZM, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Satyadivis Pharmaceuticals is U24239TG1992PTC014939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyadivis Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Satyadivis Pharmaceuticals was incorporated on 27 October 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Satyadivis Pharmaceuticals by revenue are Sanmar Speciality Chemicals Limited, Lohitha Life Sciences Private Limited, Beloorbayir Biotech Limited, Sandu Pharmaceuticals Limited, Nakoda Chemicals Ltd and 3 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramesh Babu Potluri was appointed as Additional Director on 19 Dec 2025. Suryanarayana Simhadri was appointed as Additional Director on 30 Aug 2025. Murali Krishna Prasad Divi ceased to be Director on 13 Dec 2016. Satyadivis Pharmaceuticals has 6 board changes on record in total.
Yes, Satyadivis Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0025639).
Satyadivis Pharmaceuticals has 4 MSME Form 1 returns on record between 2019 and 2020, listing 41 overdue payments to 12 micro and small suppliers. The latest return was filed on 03 Apr 2021.
Satyadivis Pharmaceuticals can be reached through the website divispharma.com. Its registered office is in Jinnaram, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages